These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32056419)

  • 61. Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Lee CJ; Savani BN; Mohty M; Labopin M; Ruggeri A; Schmid C; Baron F; Esteve J; Gorin NC; Giebel S; Ciceri F; Nagler A
    Haematologica; 2017 Nov; 102(11):1810-1822. PubMed ID: 28883081
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study.
    Bonifazi F; Solano C; Wolschke C; Sessa M; Patriarca F; Zallio F; Nagler A; Selleri C; Risitano AM; Messina G; Bethge W; Herrera P; Sureda A; Carella AM; Cimminiello M; Guidi S; Finke J; Sorasio R; Ferra C; Sierra J; Russo D; Benedetti E; Milone G; Benedetti F; Heinzelmann M; Pastore D; Jurado M; Terruzzi E; Narni F; Völp A; Ayuk F; Ruutu T; Kröger N
    Lancet Haematol; 2019 Feb; 6(2):e89-e99. PubMed ID: 30709437
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemia.
    Shimizu H; Saitoh T; Hatsumi N; Takada S; Handa H; Jimbo T; Sakura T; Miyawaki S; Nojima Y
    Leuk Res; 2013 Nov; 37(11):1477-81. PubMed ID: 24054717
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A new pattern of pulmonary graft vs host disease in a hematopoietic stem cell transplant patient.
    Wahla AS; Khan II; Loya A; Chin R
    Clin Respir J; 2015 Oct; 9(4):399-402. PubMed ID: 24725497
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Postallogeneic hematopoietic stem cell transplantation relapse of acute myeloid leukemia presenting with salivary gland myelosarcoma.
    Lai YH; Chang CS; Liu YC; Liu TC
    Ann Hematol; 2010 Jun; 89(6):631-3. PubMed ID: 19816683
    [No Abstract]   [Full Text] [Related]  

  • 66. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
    Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
    J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A case report and literature review of chronic graft-versus-host disease manifesting as polymyositis.
    Michelis FV; Bril V; Lipton JH
    Int J Hematol; 2015 Jul; 102(1):144-6. PubMed ID: 25732066
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Membranous Nephropathy with Crescent after Hematopoietic Cell Transplantation.
    Kitamura M; Hisano S; Kurobe Y; Abe S; Ota Y; Sawayama Y; Uramatsu T; Obata Y; Fukuoka J; Miyazaki Y; Mukae H; Nishino T
    Intern Med; 2019 Jan; 58(1):91-96. PubMed ID: 30146584
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Association of Nutritional Parameters with Clinical Outcomes in Patients with Acute Myeloid Leukemia Undergoing Haematopoietic Stem Cell Transplantation.
    Baumgartner A; Zueger N; Bargetzi A; Medinger M; Passweg JR; Stanga Z; Mueller B; Bargetzi M; Schuetz P
    Ann Nutr Metab; 2016; 69(2):89-98. PubMed ID: 27639391
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Unrelated stem cell transplantation after a reduced intensity conditioning regimen containing high-dose thymoglobulin leads to controllable graft-versus-host disease.
    Lacerda JF; Martins C; Lourenço F; Carmo JA; Juncal C; Oliveira JJ; Lacerda JM
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):494-7. PubMed ID: 17382257
    [No Abstract]   [Full Text] [Related]  

  • 71. To RIC or not to RIC: that is the question.
    Mohty M; Malard F
    Leukemia; 2015 Jul; 29(7):1450-1. PubMed ID: 25871984
    [No Abstract]   [Full Text] [Related]  

  • 72. Acute Ocular Graft-versus-Host Disease.
    Braun R; Holler E
    N Engl J Med; 2017 Aug; 377(7):676. PubMed ID: 28813228
    [No Abstract]   [Full Text] [Related]  

  • 73. Transmission of West Nile Virus Through a Hematopoietic Stem Cell Transplant.
    Kitagawa MG; Ettinger N; Breen D; Erklauer J; Chang E; Herce H; King K; Naik S
    J Pediatric Infect Dis Soc; 2018 May; 7(2):e52-e54. PubMed ID: 29309636
    [No Abstract]   [Full Text] [Related]  

  • 74. Peritransplant Serum Albumin Decline Predicts Subsequent Severe Acute Graft-versus-Host Disease after Mucotoxic Myeloablative Conditioning.
    Rashidi A; DiPersio JF; Westervelt P; Abboud CN; Schroeder MA; Cashen AF; Pusic I; Romee R
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1137-1141. PubMed ID: 26988741
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Reduced-intensity transplants, conventional transplants or chemotherapy for acute myeloid leukemia in 1st remission: who knows; ask your wife?
    Gale RP
    Leukemia; 2015 Jul; 29(7):1448-9. PubMed ID: 25976988
    [No Abstract]   [Full Text] [Related]  

  • 76. CR with lenalidomide in del(5)(q13q33) AML relapsing after allogeneic hematopoietic SCT.
    Ford CD; Asch J; Konopa K; Petersen FB
    Bone Marrow Transplant; 2010 Feb; 45(2):403-4. PubMed ID: 19597424
    [No Abstract]   [Full Text] [Related]  

  • 77. Early diagnosis and successful management of oral mucormycosis in a hematopoietic stem cell transplant recipient: case report and literature review.
    Epstein JB; Kupferman SB; Zabner R; Rejali A; Hopp ML; Lill M; Tzachanis D
    Support Care Cancer; 2016 Aug; 24(8):3343-6. PubMed ID: 26971955
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immune stimulation during chemotherapy increases incidence of acute graft versus host disease in acute myeloid leukemia: A study on behalf of SFGM-TC and ALFA.
    Wang L; Raffoux E; Thomas X; Yakoub-Agha I; Bouhris JH; de Botton S; Michallet M; Quoc SN; Chantepie S; Deconinck E; Caillot D; Turlure P; Vigouroux S; Pigneux A; Huynh A; Malfuson JV; Loschi M; Socie G; Dombret H; de la Tour RP; Cluzeau T
    Leuk Res; 2017 Mar; 54():12-16. PubMed ID: 28088653
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Who is the best hematopoietic stem-cell donor for a male patient with acute leukemia?
    Ringdén O; Labopin M; Solders M; Beelen D; Arnold R; Ehninger G; Milpied N; Niederwieser D; Hamladji RM; Kyrcz-Krzemien S; Ganser A; Socié G; Stelljes M; Volin L; Craddock C; Mohty M;
    Transplantation; 2014 Sep; 98(5):569-77. PubMed ID: 24798307
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Recipient and donor JAK2 46/1 haplotypes are associated with acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Balassa K; Krahling T; Remenyi P; Batai A; Bors A; Kiss KP; Torbagyi E; Gopcsa L; Lengyel L; Barta A; Varga G; Tordai A; Masszi T; Andrikovics H
    Leuk Lymphoma; 2017 Feb; 58(2):391-398. PubMed ID: 27389386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.